Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 6/20 | 0.64 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.64 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.64 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.64 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.64 |
| ▸ | CHRNA2 | Q15822 | 3/20 | 0.64 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.64 |
| ▸ | CHRNG | P07510 | 2/20 | 0.64 |
| ▸ | CHRND | Q07001 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.58 |
| ▸ | CHRNB3 | Q05901 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.58 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.58 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | HTR3B | O95264 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31019621 | 1.00 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| SCHEMBL159159 | 1.00 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| SCHEMBL159158 | 1.00 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| Acetic Acid SCHEMBL27199916 | 0.91 | CHRNB4 (0.56) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| SCHEMBL20164036 | 0.91 | CHRNB4 (0.56) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| Acetic Acid SCHEMBL31344159 | 0.91 | CHRNB4 (0.56) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| Cadaverine Tartrate SCHEMBL30866584 | 0.87 | BLM (0.67) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| Lactic Acid SCHEMBL31344162 | 0.87 | BLM (0.57) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| L-Lactic Acid SCHEMBL27199878 | 0.87 | BLM (0.57) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 | |
| Lactic Acid SCHEMBL27199874 | 0.87 | BLM (0.57) | CHRNB4CHRNA3CHRNB2CHRNA4CHRNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-09-18 | — | — | US | claimed |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-07-15 | — | — | US | claimed |
| WO-2025096261-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025058941-A1 | TOBACCO HARM REDUCTION AND PAIN RELIEF PRODUCTS AND METHODS THEREOF | Ready Mix Naturals, LLC (US) | 2025-03-20 | — | — | WO | claimed |
| US-20250082627-A1 | TOBACCO HARM REDUCTION AND PAIN RELIEF PRODUCTS AND METHODS THEREOF | Ready Mix Naturals, LLC (US) | 2025-03-13 | — | — | US | claimed |
| WO-2025049141-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-03-06 | — | — | WO | claimed |
| US-20250049096-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20240400539-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-12-05 | — | — | US | claimed |
| US-20240270711-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-08-15 | — | — | US | claimed |
| WO-2024155297-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-07-25 | — | — | WO | claimed |
| US-20240245092-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-07-25 | — | — | US | claimed |
| US-20240246930-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-07-25 | — | — | US | claimed |
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2024-04-23 | — | — | US | claimed |
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | disclosed |
| WO-2024155297-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2024-07-25 | — | — | WO | disclosed |
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2024-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246930-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | SRM, SCLY, SMOX | CHRNB4 55/4885CHRNA3 116/4885CHRNB2 98/4885 |
| US-20240400539-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | CHRM5, NNMT, CHRM1 | CHRNB4 35/4885CHRNA3 51/4885CHRNB2 82/4885 |
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CHRNB4 55/4885CHRNA3 116/4885CHRNB2 98/4885 |
| US-20250082627-A1 | TOBACCO HARM REDUCTION AND PAIN RELIEF PRODUCTS AND METHODS THEREOF | OPRK1, SYMPK, TAS2R9 | CHRNB4 244/4885CHRNA3 417/4885CHRNB2 245/4885 |
| US-20240270711-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | CHRM5, NNMT, CHRM1 | CHRNB4 35/4885CHRNA3 51/4885CHRNB2 82/4885 |
| US-20250289796-A1 | COMPOSITIONS AND METHODS OF USE THEREOF | OR10J3, TRPA1, TAS2R3 | CHRNB4 205/4885CHRNA3 173/4885CHRNB2 389/4885 |
| US-12358888-B2 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CHRNB4 55/4885CHRNA3 116/4885CHRNB2 98/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | CHRNB4 35/4885CHRNA3 51/4885CHRNB2 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.